China Universal Asset Management Co., Ltd. Atea Pharmaceuticals, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

A detailed history of China Universal Asset Management Co., Ltd. transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 16,237 shares of AVIR stock, worth $53,744. This represents 0.01% of its overall portfolio holdings.

Number of Shares

16,237

Previous 9,894 64.11%

Holding current value

$53,744

Previous $32,000 68.75%

% of portfolio

0.01%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$3.17 - $4.02 $20,107 - $25,498	6,343 Added 64.11%	16,237 $54,000
Q2 2024 Jul 19, 2024	SELL	$3.31 - $4.04 $20,803 - $25,391	-6,285 Reduced 38.85%	9,894 $32,000
Q1 2024 Apr 29, 2024	BUY	$3.09 - $4.56 $20,165 - $29,758	6,526 Added 67.61%	16,179 $65,000
Q4 2023 May 21, 2024	SELL	$2.8 - $3.35 $18,272 - $21,862	-6,526 Reduced 40.34%	9,653 $29,000
Q4 2023 Jan 23, 2024	BUY	$2.8 - $3.35 $21,039 - $25,171	7,514 Added 351.29%	9,653 $29,000
Q3 2023 May 21, 2024	BUY	$3.0 - $3.79 $3,138 - $3,964	1,046 Added 95.7%	2,139 $6,000
Q3 2023 Oct 30, 2023	BUY	$3.0 - $3.79 $3,138 - $3,964	1,046 Added 95.7%	2,139 $6,000
Q2 2023 May 21, 2024	SELL	$3.21 - $5.06 $115 - $182	-36 Reduced 3.19%	1,093 $4,000
Q2 2023 Jul 27, 2023	SELL	$3.21 - $5.06 $115 - $182	-36 Reduced 3.19%	1,093 $4,000
Q1 2023 May 21, 2024	BUY	$3.0 - $4.97 $849 - $1,406	283 Added 33.45%	1,129 $3,000
Q1 2023 Apr 27, 2023	BUY	$3.0 - $4.97 $849 - $1,406	283 Added 33.45%	1,129 $4,000
Q4 2022 May 21, 2024	SELL	$4.35 - $6.17 $66,698 - $94,604	-15,333 Reduced 94.77%	846 $4,000
Q4 2022 Jan 31, 2023	BUY	$4.35 - $6.17 $287 - $407	66 Added 8.46%	846 $4,000
Q3 2022 Oct 21, 2022	BUY	$5.49 - $8.79 $4,282 - $6,856	780 New	780 $4,000

Others Institutions Holding AVIR

# of Institutions

111

Shares Held

52.4M

Call Options Held

900

Put Options Held

126K

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $276M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account

China Universal Asset Management Co., Ltd. Atea Pharmaceuticals, Inc. Transaction History